The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Adenovirus-Based Expression Vectors and Recombinant Vaccines
Open accessAbstract
Publisher Summary This chapter reviews adenovirus-based expression vectors and recombinant vaccines. A powerful new approach to the development of vaccines is the use of microorganisms as engineered vectors for expression of genes from heterologous species. Such vectors are used in two major ways, that is, as high-level expression systems for production of antigens, or as live recombinant vaccines. It seems likely that different vectors have relative advantages and disadvantages for different applications and the development of several systems in parallel seems worthwhile. The chapter describes some of the merits and potential problems associated with the use of adenoviruses as expression vectors for production of proteins in mammalian cells, and as recombinant vaccines for immunization of humans and animals against disease. From all of the studies performed to date, human adenoviruses have considerable potential as expression vectors and live-virus vaccines for a wide variety of human and animal diseases. It has been suggested that a well-characterized adenovirus serotype, such as human adenovirus type 5, is suited to the development of oral vaccines for use in children.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Self-citationAdenovirus tripartite leader sequence enhances translation of mRNAs late after infection
Logan, J., & Shenk, T. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3655 · Cited by 198
Kaufman, R. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.689 · Cited by 135
Cited by
Grubman, M. J., & Baxt, B. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.465-493.2004 · Cited by 1,840
A protocol for rapid generation of recombinant adenoviruses using the AdEasy system
Luo, J., Deng, Z.-L., Luo, X., Tang, N., Song, W.-X., Chen, J., Sharff, K. A., Luu, H. H., Haydon, R. C., Kinzler, K. W., et al. (2007) · Nature Protocols · doi:10.1038/nprot.2007.135 · Cited by 854
Zabner, J., Couture, L. A., Gregory, R. J., Graham, S. M., Smith, A. E., & Welsh, M. J. (1993) · Cell · doi:10.1016/0092-8674(93)80063-k · Cited by 681
Chartier, C., Degryse, E., Gantzer, M., Dieterle, A., Pavirani, A., & Mehtali, M. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4805-4810.1996 · Cited by 653
Update on adenovirus and its vectors
Russell, W. C. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-11-2573 · Cited by 596
Metadata
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adenovirus-Based Expression Vectors and Recombinant Vaccines. https://app.cochat.ai/papers/10.1016/b978-0-7506-9265-6.50022-1
- The paper
- Graham, F. L., & Prevec, L. (1992). Adenovirus-Based Expression Vectors and Recombinant Vaccines. Vaccines. https://doi.org/10.1016/b978-0-7506-9265-6.50022-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.